top of page
it's where dermatology lives




1/2


Melanoma-inhibiting macrophage subtype identified
A highly magnified view of melanoma tumours growing in the skin. CD169+ macrophages are shown in green and yellow, forming a biological boundary wall to contain the tumours. Image courtesy Garvan Institute of Medical Research For the first time, researchers have observed macrophages attacking melanoma cells in real time and identified a subpopulation of the immune cells involved in resisting the skin cancer. The findings, published in the Journal of Experimental Medicine, rev
John Evans
11 minutes ago3 min read


VIDEO: Concomitant ixekizumab, tirzepatide improves skin clearance, reduces weight in PsO patients
Concomitant ixekizumab and tirzepatide improved skin clearance and reductions in weight in patients with moderate-to-severe psoriasis
Jeremy Visser
2 days ago1 min read


Lipopeptides from commensal bacteria may inhibit AD flares
Staphylococcus aureus. Photo by Janice Haney Carr, provided by CDC/ Matthew J. Arduino, DRPH, via Wikimedia Commons New findings suggest that commensal bacteria on the skin release molecules that inhibit the skin’s production of pro-inflammatory interleukin (IL)-33, potentially preventing atopic dermatitis (AD) flares. Published in Nature Communications, the findings come from research conducted at the University of Manchester and Tokyo University of Agriculture and Technolog
John Evans
May 152 min read


VIDEO: Risankizumab linked to lower risk of serious infection than other systemic treatments
Risankizumab was associated with a lower risk of serious infections when compared to other systemic treatments for psoriasis
Jeremy Visser
May 131 min read


Gut microbiome patterns predict melanoma recurrence after immunotherapy
Image by freepik The composition of gut bacteria can predict which melanoma patients will experience cancer recurrence after surgical resection and immunotherapy, but only when matched to patients with similar microbial profiles, according to research published April 17 in Cell. The findings from a 674-patient international clinical trial offer a novel approach to stratifying recurrence risk in high-risk melanoma patients undergoing adjuvant immune checkpoint blockade. Resear
Allan Ryan
May 112 min read


AAD Survey: Misinformation driving unsafe sun behaviour in the U.S.
Image courtesy the American Academy of Dermatology Findings from the American Academy of Dermatology’s (AAD) annual Practice Safe Sun Survey, released on May 1, 2026, show that misinformation, social media, and persistent tanning myths are driving many Americans to continue to engage in risky sun behaviours. A statement released by the AAD says the survey results underscore a perception gap between what Americans understand to be safe sun practices and the reality of good hab
John Evans
May 83 min read
Featured Posts


bottom of page
